Signifor (Pasireotide Extended-Release Injection) and Ultravist
Determining the interaction of Signifor (Pasireotide Extended-Release Injection) and Ultravist and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
Generic Name: iopromide
Brand name: Ultravist
Synonyms: Ultravist Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Signifor (Pasireotide Extended-Release Injection)-Ultravist Injection
- Signifor (Pasireotide Extended-Release Injection)-Ultresa
- Signifor (Pasireotide Extended-Release Injection)-Umeclidinium
- Signifor (Pasireotide Extended-Release Injection)-Umeclidinium and vilanterol
- Signifor (Pasireotide Extended-Release Injection)-Umeclidinium and vilanterol Inhalation
- Signifor (Pasireotide Extended-Release Injection)-Umeclidinium Bromide
- Ultravist-Signifor (Pasireotide Injection)
- Ultravist-Signifor Injection
- Ultravist-Signifor LAR
- Ultravist-Signifor LAR Injection
- Ultravist-Siklos
- Ultravist-Siladryl Allergy